glp-1 mcas It's wild—but true: mast cells actually have receptors on them. So yes, using a GLP-1 agonist for mast cell activation syndrome (MCAS) is a thing—and in some cases, it really helps GLP-1 Receptor Agonists: A Game-Changing
Description
GLP-1 (GLP-1R)

Protect muscle, control hunger, improve results, and support long-term weight loss.
In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need
A 43% lower risk of metastatic breast cancer progression in GLP-1 users at ASCO 2026 (hazard ratio 0.57)
